José Antonio Encinar

14PUBLICATIONS
52CO-AUTHORS
Biomolecular modelling and designMetabolic medicineMolecular targetsHost-parasite interactionsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 21, 2026
ADMET-Driven Chemical Navigability Rules for Early-Stage Virtual Compound Prioritization.

|Nov 04, 2024
PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity.

Eduardo H Gilglioni, Ao Li, Wadsen St-Pierre-Wijckmans

|Dec 23, 2022
Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors.

Sara Verdura, Jose Antonio Encinar, Eduard Teixidor

|Sep 09, 2022
Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells.

Sara Verdura, José Antonio Encinar, Salvador Fernández-Arroyo

|Jun 23, 2022
The Immune System of Marine Organisms as Source for Drugs against Infectious Diseases.

Alberto Falco, Mikolaj Adamek, Patricia Pereiro

|Oct 23, 2021
Peimine, an Anti-Inflammatory Compound from Chinese Herbal Extracts, Modulates Muscle-Type Nicotinic Receptors.

Armando Alberola-Die, José Antonio Encinar, Raúl Cobo

Pageof 3

Frequent Collaborators

5 joint publications

Javier A Menendez

4 joint publications

Joaquim Bosch-Barrera

4 joint publications

Sara Verdura

3 joint publications

Elisabet Cuyàs